Show
Sort by
-
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
-
- Journal Article
- A1
- open access
Measuring treatment effect on psoriatic arthritis-related domains : insights from the SPIRIT-H2H study at weeks 24 and 52
-
- Journal Article
- A1
- open access
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial
-
- Journal Article
- A1
- open access
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update
-
- Journal Article
- A1
- open access
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
-
- Journal Article
- A1
- open access
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target : 2017 update of recommendations by an international task force
-
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis : results from a randomised phase III trial (FUTURE 1)
-
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies : 2015 update
-
- Journal Article
- A2
- open access
Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages
-
- Journal Article
- A1
- open access
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force